Bergabunglah dengan Buletin Kami
Bergabunglah dengan daftar pelanggan kami untuk mendapatkan artikel terkini, update dan penawaran khusus langsung di kotak masuk Anda
Nikkhil Masurkar, CEO, Entod Pharmaceuticals opines that in the absence of clin...
Outcome follows Rs 825 crore CDMO mandate and supports global manufacturing eng...
Approval from Japan regulator covers API and finished dosage manufacturing unit...
This territory includes Hong Kong, Macau, Mainland China, and Taiwan. The focus ...
The agreement involves Daiichi Sankyo Research Institute Boston and aims to asse...
Lupin Pharmaceuticals Inc to pay USD 30 million under agreement without admissi...
Company to launch product for urea cycle disorders with market size of US$ 50....
The collaboration aims to bridge gaps between data generation and actionable ins...
Methotrexate Injection is a folate analog metabolic inhibitor indicated for neo...
This Phase Ib/II study will measure the tolerability, safety, and early clinical...
Transaction valued at INR 200 crore to expand presence in CNS therapies and dom...
The financing will support Adcendo’s ongoing advancement of its first-in-class a...
The acquisition includes the lead candidate CBB-120, a dual-payload antibody-dru...
Product priced lower than innovator drug and introduced for type 2 diabetes tre...
Partnership supports drug discovery programmes for obesity and metabolic diseas...
ANDA approval with CGT designation grants six-month exclusivity for parenteral ...